Newton™ (Formerly Neurolens®) Partners with Hong Kong Optical Lens to Bring Therapeutic and Preventive Vision Solutions to Hong Kong and China Markets
DALLAS, Nov. 19, 2025 /PRNewswire/ -- Newton™, Inc. (formerly Neurolens®), a leader in innovative eye care technology, today announced its expansion into Asian markets through a strategic partnership with Hong Kong Optical Lens Co Ltd (HKO) as the exclusive distributor for Hong Kong and China. This milestone in Newton's international growth brings the therapeutic solution of Neurolens for headaches, neck pain, and motion sickness, along with the everyday digital eye strain prevention of Sequel™ lenses, to millions across two of the world's most digitally connected markets.
This partnership represents Newton's first major expansion into Asia. Hong Kong's healthcare infrastructure makes it ideal for Newton's complete portfolio, while China's 1 billion internet users and position as the world's largest smartphone market creates significant opportunity for the Sequel everyday lens. The arrival of Newton's therapeutic and everyday lens solutions is eagerly anticipated across both markets.
Newton's expansion into Hong Kong is supported by HKO's strategic partner CMER Eye Centers, which has integrated the Neurolens N3 measurement device into its practice. In support of advancing eye care education, HKO, together with Newton, have donated N3 devices to The Hong Kong Polytechnic University School of Optometry, one of Asia's most prestigious optometry programs, enabling future eye care professionals to train on this innovative technology.
Newton's Vision Solutions
Neurolens Therapeutic System: The N3 diagnostic device provides objective measurement of eye misalignment. Neurolens therapeutic lenses use patented Contoured Prism™ technology to alleviate visual misalignments leading to headaches, neck pain, motion sickness, and eye strain, delivering relief for up to 90% of symptomatic patients.
Sequel Everyday Lens: Designed for daily wear to prevent and alleviate digital eye strain, proprietary Convergence Boost™ technology provides comfortable vision for extended screen time.
"This partnership marks a pivotal moment in Newton's global expansion," said Davis Corley, Newton CEO. "Hong Kong Optical Lens' market expertise positions us to bring relief to millions experiencing headaches, neck pain, motion sickness, and digital eye strain. This is just the beginning of Newton's international growth."
Eddie So, Managing Director of Hong Kong Optical Lens, added, "Our legacy is rooted in a partner-first philosophy, working closely with global brands, to transform market insights into reality. We are excited to partner with Newton to bring the cutting-edge Neurolens and Sequel technologies to Hong Kong and China."
About Newton
Newton is an innovation company transforming eye care through exceptional patient experiences and outcomes. With patented Contoured Prism technology in the Neurolens portfolio and breakthrough Convergence Boost technology in Sequel lenses, Newton empowers eye care providers to deliver measurable relief while elevating the standard of care industry wide.
For more information, visit www.newton.tech.
About Hong Kong Optical Lens
For over 50 years, Hong Kong Optical Lens Co Ltd (HKO) has stood at the forefront of Asia's optical manufacturing industry. Headquartered in Hong Kong, HKO operates a powerful integrated network—supported by 3,000 employees, 13 specialized facilities, and 8 international offices—to offer end-to-end manufacturing from concept to quality-assured delivery. By uniting cutting-edge innovation with precision manufacturing, HKO produces the next generation of high-performance lenses and frames that define market trends and meet the dynamic demands of consumers worldwide.
SOURCE Newton
Share this article